209 related articles for article (PubMed ID: 23352598)
1. Sexually dimorphic myofilament function and cardiac troponin I phosphospecies distribution in hypertrophic cardiomyopathy mice.
McKee LA; Chen H; Regan JA; Behunin SM; Walker JW; Walker JS; Konhilas JP
Arch Biochem Biophys; 2013 Jul; 535(1):39-48. PubMed ID: 23352598
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic cardiomyopathy mutations increase myofilament Ca
Robinson P; Liu X; Sparrow A; Patel S; Zhang YH; Casadei B; Watkins H; Redwood C
J Biol Chem; 2018 Jul; 293(27):10487-10499. PubMed ID: 29760186
[TBL] [Abstract][Full Text] [Related]
3. Myofilament mechanical performance is enhanced by R403Q myosin in mouse myocardium independent of sex.
Palmer BM; Wang Y; Teekakirikul P; Hinson JT; Fatkin D; Strouse S; Vanburen P; Seidman CE; Seidman JG; Maughan DW
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1939-47. PubMed ID: 18281382
[TBL] [Abstract][Full Text] [Related]
4. Desensitization of myofilaments to Ca2+ as a therapeutic target for hypertrophic cardiomyopathy with mutations in thin filament proteins.
Alves ML; Dias FAL; Gaffin RD; Simon JN; Montminy EM; Biesiadecki BJ; Hinken AC; Warren CM; Utter MS; Davis RT; Sakthivel S; Robbins J; Wieczorek DF; Solaro RJ; Wolska BM
Circ Cardiovasc Genet; 2014 Apr; 7(2):132-143. PubMed ID: 24585742
[TBL] [Abstract][Full Text] [Related]
5. Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males.
Luckey SW; Mansoori J; Fair K; Antos CL; Olson EN; Leinwand LA
Am J Physiol Heart Circ Physiol; 2007 Feb; 292(2):H838-45. PubMed ID: 17012357
[TBL] [Abstract][Full Text] [Related]
6. Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.
Sequeira V; Wijnker PJ; Nijenkamp LL; Kuster DW; Najafi A; Witjas-Paalberends ER; Regan JA; Boontje N; Ten Cate FJ; Germans T; Carrier L; Sadayappan S; van Slegtenhorst MA; Zaremba R; Foster DB; Murphy AM; Poggesi C; Dos Remedios C; Stienen GJ; Ho CY; Michels M; van der Velden J
Circ Res; 2013 May; 112(11):1491-505. PubMed ID: 23508784
[TBL] [Abstract][Full Text] [Related]
7. Mavacamten rescues increased myofilament calcium sensitivity and dysregulation of Ca
Sparrow AJ; Watkins H; Daniels MJ; Redwood C; Robinson P
Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H715-H722. PubMed ID: 32083971
[TBL] [Abstract][Full Text] [Related]
8. Rat cardiac troponin T mutation (F72L)-mediated impact on thin filament cooperativity is divergently modulated by α- and β-myosin heavy chain isoforms.
Chandra V; Gollapudi SK; Chandra M
Am J Physiol Heart Circ Physiol; 2015 Oct; 309(8):H1260-70. PubMed ID: 26342069
[TBL] [Abstract][Full Text] [Related]
9. The R21C Mutation in Cardiac Troponin I Imposes Differences in Contractile Force Generation between the Left and Right Ventricles of Knock-In Mice.
Liang J; Kazmierczak K; Rojas AI; Wang Y; Szczesna-Cordary D
Biomed Res Int; 2015; 2015():742536. PubMed ID: 25961037
[TBL] [Abstract][Full Text] [Related]
10. Pathogenesis of Hypertrophic Cardiomyopathy is Mutation Rather Than Disease Specific: A Comparison of the Cardiac Troponin T E163R and R92Q Mouse Models.
Ferrantini C; Coppini R; Pioner JM; Gentile F; Tosi B; Mazzoni L; Scellini B; Piroddi N; Laurino A; Santini L; Spinelli V; Sacconi L; De Tombe P; Moore R; Tardiff J; Mugelli A; Olivotto I; Cerbai E; Tesi C; Poggesi C
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28735292
[TBL] [Abstract][Full Text] [Related]
11. Dilated cardiomyopathy mutations in thin-filament regulatory proteins reduce contractility, suppress systolic Ca
Robinson P; Sparrow AJ; Patel S; Malinowska M; Reilly SN; Zhang YH; Casadei B; Watkins H; Redwood C
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H306-H319. PubMed ID: 32618513
[TBL] [Abstract][Full Text] [Related]
12. Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice.
Yuan CC; Muthu P; Kazmierczak K; Liang J; Huang W; Irving TC; Kanashiro-Takeuchi RM; Hare JM; Szczesna-Cordary D
Proc Natl Acad Sci U S A; 2015 Jul; 112(30):E4138-46. PubMed ID: 26124132
[TBL] [Abstract][Full Text] [Related]
13. Sex dimorphisms of crossbridge cycling kinetics in transgenic hypertrophic cardiomyopathy mice.
Birch CL; Behunin SM; Lopez-Pier MA; Danilo C; Lipovka Y; Saripalli C; Granzier H; Konhilas JP
Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H125-36. PubMed ID: 27199124
[TBL] [Abstract][Full Text] [Related]
14. Measurement of Myofilament-Localized Calcium Dynamics in Adult Cardiomyocytes and the Effect of Hypertrophic Cardiomyopathy Mutations.
Sparrow AJ; Sievert K; Patel S; Chang YF; Broyles CN; Brook FA; Watkins H; Geeves MA; Redwood CS; Robinson P; Daniels MJ
Circ Res; 2019 Apr; 124(8):1228-1239. PubMed ID: 30732532
[TBL] [Abstract][Full Text] [Related]
15. Mutation location of HCM-causing troponin T mutations defines the degree of myofilament dysfunction in human cardiomyocytes.
Schuldt M; Johnston JR; He H; Huurman R; Pei J; Harakalova M; Poggesi C; Michels M; Kuster DWD; Pinto JR; van der Velden J
J Mol Cell Cardiol; 2021 Jan; 150():77-90. PubMed ID: 33148509
[TBL] [Abstract][Full Text] [Related]
16. Fropofol prevents disease progression in mice with hypertrophic cardiomyopathy.
Huang Y; Lu H; Ren X; Li F; Bu W; Liu W; Dailey WP; Saeki H; Gabrielson K; Abraham R; Eckenhoff R; Gao WD
Cardiovasc Res; 2020 May; 116(6):1175-1185. PubMed ID: 31424496
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca
Zhang J; Wang L; Kazmierczak K; Yun H; Szczesna-Cordary D; Kawai M
FEBS J; 2021 Aug; 288(15):4596-4613. PubMed ID: 33548158
[TBL] [Abstract][Full Text] [Related]
18. Generation and functional characterization of knock-in mice harboring the cardiac troponin I-R21C mutation associated with hypertrophic cardiomyopathy.
Wang Y; Pinto JR; Solis RS; Dweck D; Liang J; Diaz-Perez Z; Ge Y; Walker JW; Potter JD
J Biol Chem; 2012 Jan; 287(3):2156-67. PubMed ID: 22086914
[TBL] [Abstract][Full Text] [Related]
19. The effect of cardiomyopathy mutation (R97L) in mouse cardiac troponin T on the muscle length-mediated recruitment of crossbridges is modified divergently by α- and β-myosin heavy chain.
Gollapudi SK; Chandra M
Arch Biochem Biophys; 2016 Jul; 601():105-12. PubMed ID: 26792537
[TBL] [Abstract][Full Text] [Related]
20. L71F mutation in rat cardiac troponin T augments crossbridge recruitment and detachment dynamics against α-myosin heavy chain, but not against β-myosin heavy chain.
Reda SM; Gollapudi SK; Chandra M
J Muscle Res Cell Motil; 2016 Dec; 37(6):215-223. PubMed ID: 27975185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]